Increase in cortisol/ACTH ratio after chronic treatment with liraglutide in patients with type 2 diabetes

Diabetes Metab. 2017 Sep;43(4):398-399. doi: 10.1016/j.diabet.2017.01.008. Epub 2017 Mar 7.

Authors

S Kamei¹, H Kaneto², A Tanabe², T Kinoshita², A Obata², T Kimura², H Hirukawa², F Tatsumi², M Shimoda², K Kohara², Takatoshi Anno², S Nakanishi², T Mune², K Kaku²

Affiliations

¹ Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, 701-0192 Kurashiki, Japan. Electronic address: [email protected].
² Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, 577 Matsushima, 701-0192 Kurashiki, Japan.

PMID: 28283288
DOI: 10.1016/j.diabet.2017.01.008

No abstract available

Keywords: ACTH; Cortisol; GLP-1; Liraglutide.

Publication types

Letter

MeSH terms

Adrenocorticotropic Hormone / blood*
Adult
Aged
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / drug therapy*
Female
Humans
Hydrocortisone / blood*
Hypoglycemic Agents / therapeutic use*
Liraglutide / therapeutic use*
Male
Middle Aged

Substances

Hypoglycemic Agents
Liraglutide
Adrenocorticotropic Hormone
Hydrocortisone